A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

The parents of Elizabeth Rose Struhs, who died in 2022, were part of a small religious sect in Australia that believed that ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.